title: [Significance of intravenous immunoglobulins to the neonate born of a mother with idiopathic thrombopenic purpura].
abstract: High dose gammaglobulin therapy for pregnant women with idiopathic thrombocytopenic purpura may be suitable for both mother and foetus during pregnancy. A newborn with severe thrombocytopenia secondary to maternal illness, was treated successfully by intravenous gammaglobulin, without toxicity. In such a case, we believe the platelet count is not the only criterion for starting immunoglobulin therapy.
authors: C.D.T.S. de l'Indre, Châteauroux.
authors: J
authors: J
authors: Klein
authors: P
authors: P
authors: Sanyas
authors: G
authors: G
authors: Dauptain
authors: P
authors: P
authors: Arsac
authors: J P
authors: JP
authors: Delaup
mesh_terms: D000328:Adult; D005260:Female; D006801:Humans; D007116:Immunization, Passive; D007231:Infant, Newborn; D010976:Platelet Count; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000188:drug therapy* / Q000276:immunology; D011696:Purpura, Thrombocytopenic / Q000188:drug therapy* / Q000276:immunology
vernacular_title: Intérêt des immunoglobulines intraveineuses chez le nouveau-né de mère atteint de purpura thrombopénique idiopathique.